FOXO4-DRI (10mg)
Experimental FOXO4-p53 Interaction Research Peptide
Order FOXO4-DRI (10mg) online for laboratory research with US shipping options at checkout. Compare the listed vial options and current price, then add your selection to cart and continue to checkout. Review available COA records for the exact product, strength and lot. Research Use Only; not for human or veterinary use.
FOXO4-DRI is listed for longevity laboratory research. Catalog vial contents are 10mg; select the required strength before ordering. This material is supplied for Research Use Only, not as a medicine or a product for human or veterinary use.
Buy FOXO4-DRI online with US shipping
Paid, in-stock orders placed before 1:00 PM Central Time on business days are scheduled to ship the same day.
Standard domestic delivery generally takes 2–5 business days after dispatch, not after placing the order.
Enter your full shipping address at checkout to confirm available shipping methods and cost. Delivery varies by ZIP code and carrier; weekends, holidays and carrier delays can affect arrival. These are online shipping destinations, not local stores or pickup locations.
FOXO4-DRI shipping to New York, NY
Ordering for a research address in New York? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.
FOXO4-DRI shipping to Los Angeles, CA
Ordering for a research address in Los Angeles? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.
FOXO4-DRI shipping to Chicago, IL
Ordering for a research address in Chicago? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.
FOXO4-DRI shipping to Houston, TX
Ordering for a research address in Houston? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.
FOXO4-DRI shipping to Phoenix, AZ
Ordering for a research address in Phoenix? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.
FOXO4-DRI shipping to Miami, FL
Ordering for a research address in Miami? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.
FOXO4-DRI shipping to Atlanta, GA
Ordering for a research address in Atlanta? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.
FOXO4-DRI shipping to Seattle, WA
Ordering for a research address in Seattle? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.
Research Applications & Benefits
- Senescence-pathway research
- FOXO4-p53 interaction studies
- D-retro-inverso peptide design
- Preclinical laboratory reagent
What is FOXO4-DRI?
A D-retro-inverso experimental peptide studied in preclinical senescent-cell models through disruption of FOXO4-p53 interaction.
Listed vial contents: 10mg. These are supplied quantities, not administration doses. Current pricing and availability are shown in the strength selector.
What mechanisms are being studied?
FOXO4-DRI was designed to interfere with FOXO4-p53 binding in senescent cells. In preclinical models this interaction was associated with p53 exclusion and apoptosis; translation beyond those models remains uncertain.
What are the research questions?
- Cellular-senescence pathway studies
- FOXO4/p53 protein-interaction research
- D-retro-inverso peptide pharmacology
What does the published work describe?
Baar et al. reported effects in cultured cells and aged-mouse models. This is early preclinical evidence, not proof of safety or efficacy in humans.
What are the limits of this evidence?
The research described concerns the cited experimental materials and models, not proof that this supplied vial is a treatment. Cell or animal findings do not establish human benefits. Clinical findings, where cited, apply to the tested formulation and population; they do not validate this research product for human use.
Study references
- Baar MP et al. Cell. 2017;169:132-147.e16
These are the catalog's existing bibliographic references. No new source verification is implied by this presentation.
How should I check lot documentation?
Match the product, strength and lot to an original analysis document. Literature describes experimental findings; it does not verify the contents of this inventory. A report is evidence only for the product, strength and lot it names.
How is FOXO4-DRI handled in the lab?
For FOXO4-DRI, record the product code FOXO4-10, selected strength and lot before opening. Follow the material-specific safety data sheet and laboratory SOP, with appropriate gloves, eye protection and containment. For a documented dry preparation, let the sealed vial equilibrate before opening to reduce condensation; minimize time open and use clean, compatible vessels.
Choose a solvent for FOXO4-DRI from the documented sequence or chemical identity, salt form and assay requirements. Test a small portion first and record pH, solvent composition and clarity. Do not assume one diluent works for every research material; include a solvent-only control and establish compatibility before using the stock in an assay.
For FOXO4-DRI, calculate mass concentration as measured material mass divided by final solution volume. Calculate molarity only with a documented molecular weight for the supplied chemical form; the catalog lists ~5358 g/mol as a reference, not lot confirmation. Where available, use matched-lot net content rather than treating chromatographic purity as a mass correction. Record both stock concentration and subsequent dilution factors.
Use the documented storage conditions for the supplied FOXO4-DRI form and lot. For a documented lyophilized preparation, keep the vial sealed and protected from moisture; for solutions, validate temperature, light exposure and holding time in the assay. Use compatible single-use aliquots when appropriate to reduce repeated freeze-thaw. No universal temperature or 28-day solution shelf life is established by the catalog name.
A FOXO4-DRI laboratory protocol should record identity, product code FOXO4-10, strength, lot, applicable analysis results, solvent and pH, stock concentration, dilution sequence, vessel type, storage history and assay endpoints. Include vehicle and reference controls, independent replicates and predefined acceptance criteria. Separate handling validation from biological interpretation; these notes do not provide administration or dosing instructions.
Research Use Only. Not for human consumption, therapeutic, veterinary or any in-vivo use.
Product Specifications
- Compound
- FOXO4-DRI
- CAS Number
- N/A
- Molecular Weight
- ~5358 g/mol
- HPLC Purity Specification
- ≥99%
- Category
- Longevity
- Starting Price
- $149.00 USD
- Country of Origin
- United States
- Shipping
- Cold-chain insulated packaging, fast domestic delivery
- Payment
- Card, ACH, and cryptocurrency (10% discount)
Quality & Verification
FOXO4-DRI has a catalog purity specification of ≥99%; this is not a measured result for every vial. Match the product, exact strength, batch and lot to its analysis record and read only the reported fields. HPLC peak-area purity, measured content and endotoxin are separate measurements. A blank field means no result is reported, not zero or passed. A purity percentage alone does not establish identity, sterility or suitability for human use.
Frequently Asked Questions
What is FOXO4-DRI?
FOXO4-DRI is listed for longevity laboratory research. Catalog vial contents are 10mg; select the required strength before ordering. This material is supplied for Research Use Only, not as a medicine or a product for human or veterinary use.
What strengths of FOXO4-DRI are available?
The catalog lists 10mg. These labels describe vial contents, not administration doses. Select the required strength for current pricing and availability; match analysis records to that exact strength and lot.
How should I interpret FOXO4-DRI purity results?
FOXO4-DRI has a catalog purity specification of ≥99%; this is not a measured result for every vial. Match the product, exact strength, batch and lot to its analysis record and read only the reported fields. HPLC peak-area purity, measured content and endotoxin are separate measurements. A blank field means no result is reported, not zero or passed. A purity percentage alone does not establish identity, sterility or suitability for human use.
How should FOXO4-DRI be handled in the laboratory?
For FOXO4-DRI, record the product code FOXO4-10, selected strength and lot before opening. Follow the material-specific safety data sheet and laboratory SOP, with appropriate gloves, eye protection and containment. For a documented dry preparation, let the sealed vial equilibrate before opening to reduce condensation; minimize time open and use clean, compatible vessels.
How do I choose a laboratory solvent for FOXO4-DRI?
Choose a solvent for FOXO4-DRI from the documented sequence or chemical identity, salt form and assay requirements. Test a small portion first and record pH, solvent composition and clarity. Do not assume one diluent works for every research material; include a solvent-only control and establish compatibility before using the stock in an assay.
How do I calculate a FOXO4-DRI stock concentration?
For FOXO4-DRI, calculate mass concentration as measured material mass divided by final solution volume. Calculate molarity only with a documented molecular weight for the supplied chemical form; the catalog lists ~5358 g/mol as a reference, not lot confirmation. Where available, use matched-lot net content rather than treating chromatographic purity as a mass correction. Record both stock concentration and subsequent dilution factors.
How should FOXO4-DRI be stored after preparation?
Use the documented storage conditions for the supplied FOXO4-DRI form and lot. For a documented lyophilized preparation, keep the vial sealed and protected from moisture; for solutions, validate temperature, light exposure and holding time in the assay. Use compatible single-use aliquots when appropriate to reduce repeated freeze-thaw. No universal temperature or 28-day solution shelf life is established by the catalog name.
What should a FOXO4-DRI lab protocol document?
A FOXO4-DRI laboratory protocol should record identity, product code FOXO4-10, strength, lot, applicable analysis results, solvent and pH, stock concentration, dilution sequence, vessel type, storage history and assay endpoints. Include vehicle and reference controls, independent replicates and predefined acceptance criteria. Separate handling validation from biological interpretation; these notes do not provide administration or dosing instructions.
Does Fmoc or Boc synthesis explain this FOXO4-DRI product?
Fmoc and Boc are peptide protecting-group strategies, not proof of how this FOXO4-DRI lot was made. For sequence-defined peptides, synthesis review can examine deletion products, incomplete deprotection and modifications using the method and matching analytical evidence. A single chromatographic peak does not by itself establish sequence.
Is FOXO4-DRI for human use?
No. FOXO4-DRI is strictly Research Use Only. It is not intended for human or veterinary use, diagnosis or treatment. Laboratory handling guidance is not an administration protocol.
Research Use Only. This product is intended for licensed laboratory research and is not for human or veterinary use.
